Quarterly report pursuant to Section 13 or 15(d)

ACQUISITIONS - Narrative (Details)

v3.23.1
ACQUISITIONS - Narrative (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended
Sep. 30, 2021
Mar. 31, 2022
Mar. 31, 2023
Dec. 31, 2022
Sep. 10, 2021
Business Acquisition [Line Items]          
Contingent consideration liabilities - current portion     $ 3,109 $ 3,398  
Nature's Remedy          
Business Acquisition [Line Items]          
Contingent consideration, equity interest issued and issuable         $ 5,000
Contingent consideration, liability, monthly earnout $ 278        
Contingent consideration, liability, earnout calculation, ratio to share price $ 1,667        
Contingent liability     3,109 4,793  
Contingent consideration liabilities - current portion     $ 1,667 3,398  
Other liabilities - non-current       $ 1,395  
Nature's Remedy | Milestone Period One          
Business Acquisition [Line Items]          
Contingent consideration period 12 months        
Nature's Remedy | Milestone Period Two          
Business Acquisition [Line Items]          
Contingent consideration period 30 months        
Nature's Remedy | Monthly Milestone Period One          
Business Acquisition [Line Items]          
Contingent consideration period 18 months        
Nature's Remedy | Monthly Milestone Period Two          
Business Acquisition [Line Items]          
Contingent consideration period 24 months        
Nature's Remedy | Monthly Milestone Period Three          
Business Acquisition [Line Items]          
Contingent consideration period 30 months        
Apothecarium          
Business Acquisition [Line Items]          
Contributed revenues   $ 556      
Contributed net income   $ 55